Red blood cell (RBC) traits provide insight into a wide range of physiological states and exhibit moderate to high heritability, making them excellent candidates for genetic studies to inform underlying biologic mechanisms. Previous RBC trait genome-wide association studies were performed primarily in European-or Asian-ancestry populations, missing opportunities to inform understanding of RBC genetic architecture in diverse populations and reduce intervals surrounding putative functional SNPs through fine-mapping. Here, we report the first fine-mapping of 6 corre- 
| I N T R O D U C T I O N
Together, primary and derived RBC trait deficiencies (e.g., abnormally low HGB or excessive RBC count) cause circulatory diseases such as thalassemia, polycythemia, and genetic or nonhereditary anemias. [1] [2] [3] [4] [5] Population-specific HBB causal alleles for recessive diseases such as sickle-cell anemia and b-thalassemia have also been associated with protection against malaria and myocardial infarction, respectively, in the heterozygous state. [6] [7] [8] Additionally, RBC traits have been associated with stroke, cardiovascular disease (CVD) in populations with chronic kidney disease, and all-cause mortality. [9] [10] [11] [12] RBC traits are therefore of substantial public health and clinical importance, yet their underlying pathophysiological mechanisms remain incompletely characterized.
As RBC traits exhibit moderate to high heritability (40%-90%),
population-based genetic analysis of these phenotypes can help identify causal alleles for and inform the underlying biology of RBC-related disorders. 3, 13, 14 To date, over 80 independent association signals with one or more RBC traits have been reported, primarily in studies of
European-or Asian-ancestry populations. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] One genome-wide association study (GWAS) performed in over 16 000 African Americans identified 12 genome-wide-significant loci previously reported in European-ancestry or Japanese populations, indicating a shared role for common variants at RBC trait association signals. 16 However, finemapping of RBC trait associations identified in GWAS has had limited success narrowing broad GWAS signals to prioritize functional candidates because of large linkage disequilibrium (LD) blocks or characterizing variants that are rare or monomorphic in Europeans or Asians, as has been demonstrated for platelet count. 25, 26 Narrowing and finemapping of previously identified association signals may be improved by performing analyses in ancestrally diverse populations with multicontinental admixture, including African Americans and Hispanics/ Latinos. 16, 17, 27 Here, we evaluated 32 index SNP-RBC trait associations in 11 fine-mapped Metabochip regions, previously identified in populations of European-, Japanese-, and South Asian descent (SPTA1, BCL11A, HFE, ABO, HK1, SH2B3/ATXN2, LIPC, PPCDC, NUTF2, NEUROD2, and TMPRSS6) for evidence of generalization and locus refinement in African American and Hispanic/Latino participants of the Population Architecture using Genomics and Epidemiology (PAGE) consortium. 28 Additionally, we evaluated all SNPs genotyped on the Metabochip for associations not previously described in any of the 6 RBC traits. These efforts will help address gaps in understanding the genetic underpinnings of RBC traits.
| M A T E R I A L S A N D M E T H O D S

| Study populations
The PAGE consortium is a National Human Genome Research Institute funded effort to examine the epidemiologic architecture of genetic variants associated with human diseases and traits across diverse populations. 29 The following PAGE I studies contributed to this manuscript (Supplemental Materials and Methods): the Atherosclerosis Risk in
Communities Study (ARIC), 30 the Coronary Artery Risk Disease in Young Adults study (CARDIA), 31 the Cardiovascular Health Study (CHS), 32 the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), 33 and the Women's Health Initiative (WHI). 34 The Icahn
Mt. Sinai School of Medicine (MSSM) contributed both African American and Hispanic/Latino study populations separately from PAGE I. 29 The Institutional Review Board at all participating institutions approved the study protocol and all participants gave written consent.
| Genotype platforms
The Metabochip was a custom Illumina iSELECT array that contained approximately 195 000 SNPs and was designed to support large scale follow-up of putative associations for cardiovascular and metabolic traits. 28 Further information on genotyping and quality control is provided in the supplemental material. We defined an index SNP as a SNP reported in the GWAS catalog prior to October 1, 2016, as having a genome-wide significant association (5 3 10
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) with at least one of the 6 RBC traits we evaluated. Index SNPs that were not directly genotyped on the Metabochip were represented by proxies, defined as SNPs in high LD (r 2 0.80) with the GWAS index SNP in the ancestral population in which the association was first reported. For one index SNP, rs671 (ALDH2), no proxy was available because this variant is specific to populations of East Asian ancestry. A total of 74% of participants were directly genotyped on the Illumina custom Metabochip array; genotypes for the remaining participants were imputed from the Affymetrix 6.0 panel. 35 After QC and study-population-specific effective heterozygosity criteria were applied, 163 929 SNPs were available for analysis in African Americans and 159 467 SNPs were available for analysis in Hispanics/Latinos.
| Statistical analysis
We performed 4 types of analysis: (1) 
| Generalization
We defined an "association signal" as a set of SNPs genotyped in a Metabochip fine-mapped region and exhibiting linkage disequilibrium (r 2 0.2 in the Malm€ o Diet and Cancer Study) with a previously reported genome-wide significant SNP for one or more RBC traits. For 2 or more previously reported genome-wide-significant SNPs to be considered within the same association signal in our study, those variants had to be in LD.
We next defined an "index SNP" as the most significant previously reported SNP within an association signal for each RBC trait. In instances for which multiple SNPs were published as the most significant SNP within a particular association signal for the same trait, we selected the SNP with the lowest reported p-value as the index SNP.
The index SNP within an association signal may vary by trait because of differences in sample size, measurement error, and allelic heterogeneity among other possible reasons related to genetic architecture of the traits. Therefore, we evaluated the most significant SNP reported for each association signal-trait combination rather than selecting one index SNP to evaluate in all traits for which that association signal was previously reported as genome-wide-significant, even though some of the index SNPs likely tag the same genetic association across multiple RBC traits. For example, the SH2B3/ATXN2 association signal has been reported for multiple RBC traits with the most significant SNP differing by trait, meaning the index SNP for RBC count is rs3184504 whereas the index SNP for hematocrit is rs11065987. 
| Fine-mapping generalized associations
We evaluated association-signal narrowing across ancestral backgrounds by comparing the number of SNPs in high LD with the transethnic lead SNP, as well as the width of the region covered by the high-LD SNPs (Table 2, Figure 1 and Supporting Information Figure   S2 ). LD for African Americans was calculated using ARIC study participants; LD for Hispanics/Latinos was calculated using HCHS/SOL study participants.
| Independent and discovery SNP identification
To identify independent SNPs influencing RBC traits, we identified all 
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, and only considered SNPs with an effective heterozygosity >30 in more than one cohort study population per race/ethnicity.
| Bioinformatic characterization of RBC trait loci
For each of the significant RBC trait SNPs (i.e., any lead SNP that gen- was performed using Blueprint for relevant blood tissues. 46 All functional elements that varied by cell type were restricted to RBC-relevant tissues (Supporting Information Tables S12a, S12b).
In order to evaluate the relevance of trans-ethnic PAGE lead SNPs across tissue types, we compared the eQTL status of index SNPs in both blood-relevant and other tissues (Supporting Information Table   S13 ). We looked up significant eQTLs for each index SNP (p < 1E-06)
in whole blood in GTEx, which provides data on a wide array of tissues;
and 2 blood-specific eQTL databases: the blood eQTL browser; and the NESDA NTR Conditional eQTL catalog. [47] [48] [49] Only GTEx tissues which showed an association with at least one SNP are reported. We further reported clinical relevance of the trans-ethnic lead SNPs as described in the literature. Table S9 ). For the remaining 8 nongeneralized index SNP-trait associations with sufficient information to evaluate directional consistency, 6 were directionally consistent in the trans-ethnic population.
Additionally, when compared to SNP-trait associations from a previously published RBC trait GWAS, 7 of 11 PAGE lead SNPs exceeded the generalization significance threshold in 24 167 participants of the CHARGE consortium (Supporting Information Table S14 ). 17 In race/ethnicity-specific meta-analyses ( Table 2, Supporting Information Tables S6-S8) 
| Novel independent signals in 11 fine-mapped regions
We next evaluated the 11 fine-mapped regions to identify significant variants independent of published association signals by examining all
SNPs that were uncorrelated with any of the index SNPs (see Methods). We identified no independent associations in previously reported regions for any of the 6 RBC traits (significance threshold: p < 1.3 3
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).
| Fine-mapping
To fine-map association signals that generalized, we then evaluated the LD structure in the trans-ethnic study population and by race/ethnicity ( Figure 1 and Supporting Information FigureS2, Table 2 
| Discovery
Next, all SNPs outside the 11 previously identified RBC trait-associated regions were evaluated for evidence of discovery associations (p < 3.03 Table S11 ). This SNP was also nominally significant for HCT and HGB (p < 0.05).
In silico bioinformatics analysis
All SNPs highly correlated (r 2 0.9 in relevant AFR or AMR 1000
Genomes Phase I ancestral populations) with trans-ethnic lead SNPs from generalization analysis were examined using publicly available functional prediction data for erythrocytes or erythroblastoid cell lines, as well as pathogenicity prediction (Supporting Information Tables S12a, S12b). 52 With the exception of the well-established TMPRSS6 AJH AJH | 5 Table S13 ).
17
TABLE 1
Association results examining evidence of generalization to a PAGE trans-ethnic population for 13 RCB trait association signals Table S5 ).
f Index SNP and lead SNP are the same. AfAm, African American; Hisp, Hispanic; CAF, coded allele frequency; SNP, single nucleotide polymorphism.
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AJH AJH | 7 TABLE 2 Narrowing of generalized fine-mapped RBC trait association signals using LD* with lead SNPs Tables S12a, S12b).
We also evaluated tissue specificity of significant eQTLs (p < 1E-06) for each published index SNP or trans-ethnic lead SNP for all generalized association signals, as well as the putative clinical relevance of each SNP when information was available (Supporting Information   Table S13 ). 
| DISCUSSION
In this study we performed generalization, fine-mapping, and discovery analysis of 6 RBC traits in a population of over 38 000 African American and Hispanic/Latino PAGE participants. We demonstrated that genetic regions influencing RBC traits identified in European-and Asian-ancestry populations are also applicable to African American and Hispanic/Latino populations. The merits of incorporating multi-ethnic study populations in genomic studies were also displayed via locus refinement and identification of a previously unreported RBC trait association that warrants validation in future studies.
In the 11 fine-mapped regions we evaluated, over half of known variants, but fine-mapping is particularly well suited to this type of exercise. In the era of precision medicine, as interest in genetic risk scores for RBC traits increases for conditions such as pregnancy, cardiovascular and neurological diseases, and mortality, studies examining generalization of reported loci to global populations will become even more important. 22, [56] [57] [58] [59] Over the past decade, GWAS have identified hundreds of loci associated with RBC traits, but these findings incompletely account for the population-level variability attributable to additive genetic effects.
A possible explanation for this missing heritability is that all genes expressed within RBC-relevant tissues play a role in RBC trait biology, but their identification would require near-infinite statistical power. 60 A recent review described the suite of genes affecting complex traits as including both "core" genes (i.e., those with tissue-specific effects crucial to one or few complex traits) and "peripheral" genes (i.e., those with broad expression profiles playing a role in many traits). 61 Distinguishing core from peripheral genes may inform canonical pathways for RBC traits, provide mechanistic insight into biology, and inform targets for pharmaceutical intervention. 60, 61 Importantly, this designation occurs on a spectrum, with some genes not clearly predisposed to one class over the other. For example, hexokinase 1 (HK1) is highly and ubiquitously expressed, and several GWAS have identified associations within 200 kb of HK1 for psychiatric phenotypes, autoimmune disorders, and blood metabolite levels. 17, 62 However, HK1 was also the only generalized association signal in our study with evidence of a bloodspecific eQTL, which localized to a narrow segment of intron 4 repre- The PAGE consortium thanks the staff and participants of all PAGE studies for their important contributions.
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